Defending Your Brand



Defending Your Brand From Attack By Drug Counterfeiters and Illegal Diverters

Your office Nov. 22, 2013

Defending Your Brand From Attack By Drug Counterfeiters and Illegal Diverters

Please download today's presentation here.

Counterfeit drugs can destroy in minutes a reputation that took your company years to build. Read on to learn how savvy drugmakers are fighting counterfeiting — and winning ...

What’s the difference between a counterfeit $100 bill and a counterfeit drug?

The $100 bill won’t kill you. The drug might.

It might kill your reputation, too, and trigger multimillion-dollar lawsuits that tie your legal team in knots.

The problem is real for drugmakers like you. Counterfeit Avastin and Altuzan from abroad may have found its way to oncologists — and patients — nationwide. The FDA began issuing alerts in February 2012 and two licensed wholesale drug distributors have been named. Whether they were conducting legitimate transactions involving FDA-approved drugs, or doing something illegal, is not yet known.

Now FDAnews, in conjunction with top legal experts, is presenting a strategy to help you toughen anti-counterfeiting and anti-diversion efforts and prepare for the future.

Mark your calendar for Friday, Nov. 22, when Rob Reznick and Liz Howard of Orrick Herrington & Sutcliffe show how to build anti-counterfeiting protection strategies into every phase of your operations. SPECIAL: This webinar will also include updates from October’s important meeting of the drug industry anti-counterfeiting association, the Pharmaceutical Security Institute (PSI), in Shanghai. Rob Reznick is the association’s outside counsel and Corporate Secretary.

In a fast-paced 90-minute “chalk talk,” Mr. Reznick and Ms. Howard will help you:

Understand the worldwide problem of counterfeit and otherwise illegal medicines from the viewpoint of Rx manufacturers Implement best practices for building a solid anti-counterfeiting protection strategy by learning from the mistakes others have made Discover the current worldwide status of counterfeit and illegal medicines — origin, prevalence and distribution Thwart counterfeiters via better supply-chain management, disruption of illegal distribution routes, Internet strategies and more effective use of the courts And much more

You’ll hear the latest counterfeiting stories from China, perhaps the greatest global offender, and learn ways to protect your company and its products. You’ll gain insight into integrating federal and state track-and-trace regulations into supply chain management strategies.

Counterfeiting and illegal medicines are urgent topics — too urgent for a fly-in conference that’d take months to prepare. That’s why FDAnews has brought this learning event straight to your desktop via the Internet.

Right — no travel hassles, no rooms to book, no time spent away from important work and family matters. You participate directly from the convenience of your office, conference room or auditorium.

And because the event is web-based, your participation is interactive. Send in your questions via email for answers by the time the session ends.

Invite your lawyers! Indeed, invite every member of your manufacturing, quality and regulatory team. The registration fee is the same regardless of number of attendees, as long as they’re all in the same room. Generous multi-site discounts are available, too. For details, call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally.

Counterfeiting menaces your business … and it’s growing. You need tools to secure your supply chain, choke off illegal distribution, disrupt fraudulent Internet sales, and use the courts to maximum effectiveness. Delaying just makes things worse. Do yourself and your colleagues a service.